Souvenaid results lead way for more research on nutrition

31 October 2017 – The Lancet Neurology has published the full results of a large-scale study into the effects of health supplement Souvenaid™. The results do not show a significant improvement in cognition but do show some promising findings for continuing research into nutrition and dementia.

Souvenaid™ is a medicinal drink developed by Nutricia, that contains a combination of fatty acids, vitamins and other nutrients that may be beneficial to brain health. The results of the EU LipiDiDiet clinical trial examined the effect of the supplement on 311 people with Mild Cognitive Impairment (MCI), including the pre-dementia stage of Alzhiemer’s disease. The trial failed to identify a significant improvement in cognitive function measured through a series of thinking and memory tests after 2 years but showed some reduction in the decline of some people with minor problems with memory.

The study also showed that individuals at an early staqe in the development of dementia who drank Souvenaid daily showed less shrinkage in certain areas of the brain associated with memory.

Someone in the world develops dementia every three seconds. The number of people living with Alzheimer’s dementia is expected to double every 20 years, reaching 75 million in 2030.

ADI welcomes the results of the study, that highlight the important role of nutrition on brain health and continue to inform a better understanding of the impact of possible nutritional interventions on dementia in the future.

More research is needed, but it is important to remember that a healthy diet and active lifestyle play a vital role in overall health and can reduce your risk of dementia, by maintaining brain health and reducing the risk of stroke.

Chris Lynch, Policy, Communications and Publications Director and Deputy CEO said, “It is interesting to see these results. While the study didn’t show the hoped for wider improvements in cognition or evidence of a slowing of disease progression, we are certainly keen to hear more about the findings in relation to memory improvements and we welcome Nutricia’s commitment to further research in this area”

Dr Serge Gauthier, Chair of ADI’s Scientific and Medical Advisory Panel, said, “‘Important lessons were learned from this clinical trial, which will improve study designs for future preventive studies.”

ADI urges that individuals worried about, or living with dementia or MCI to always consult their doctor when considering nutritional interventions. Alzheimer associations in over 100 countries provide support and advice for anyone affected by dementia.

Where next?